IEEE 2621.3-2022 /UL 2621-3-2022

This recommended practice specifies recommendations for the use of consumer mobile devices (CMDs) in the control of diabetes-related medical devices. While these recommendations may be applied to other medical use cases, they are targeted specifically for diabetes related control use cases. The following two use cases are covered by this recommended practice: open loop remote control and automated insulin dosing (AID) systems. In general, the recommendations within this recommended practice apply to both use cases unless explicitly indicated otherwise.